GlassScriptPhysician profile
James P Flanagan
NPI 1992779656
$6,884.85
in general payments reported to CMS, 2019-2025
27 companies · $2,055 in 2025
The $2,055 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,375 · 2020: $298 · 2021: $266 · 2022: $660 · 2023: $62.72 · 2024: $169 · 2025: $2,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,752 · Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,752.19 |
| Food and Beverage | $534.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,193.40 | 2019-2025 | Journey II, Real Intelligence, Redapt |
| Stryker Corporation | $1,297.68 | 2019-2021 | |
| Boston Scientific Corporation | $182.44 | 2021-2022 | |
| Amgen INC. | $165.26 | 2019-2024 | Krystexxa |
| Depuy Synthes Sales INC. | $157.03 | 2019-2025 | Attune |
| Anika Therapeutics, INC. | $125.14 | 2024 | X-Twist, Tactoset, Integrity |
| Orthofix Medical, INC. | $94.01 | 2019-2023 | Physio-Stim |
| Radius Health, INC. | $86.63 | 2019-2021 | |
| Arthrosurface Incorporated | $70.74 | 2019 | |
| Ermi LLC | $65.23 | 2019 | |
| Pacira Therapeutics, INC. | $54.54 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $48.37 | 2019-2020 | |
| Medtronic USA, INC. | $44.31 | 2019-2020 | |
| Bioventus LLC | $42.89 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $31.66 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $29.91 | 2021 | |
| Avanos Medical | $28.87 | 2019 | |
| Djo, LLC | $28.00 | 2019-2020 | |
| Fidia Pharma USA INC. | $21.20 | 2019 | |
| Acera Surgical, INC. | $19.10 | 2022 | |
| Medacta USA, INC. | $17.81 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $15.24 | 2021 | |
| Horizon Therapeutics Plc | $14.85 | 2023 | Krystexxa |
| Apria Healthcare LLC | $13.71 | 2021 | |
| Axogen | $13.55 | 2019 | |
| Next Science LLC | $11.97 | 2020 | |
| Convatec INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Flanagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.